Is There a Difference Between Relapsing Polykondritis and GPA?

Safety parameters in psoriatic arthritis are much better looking than they are in RA and IBD. It was lower with the IL-17 inhibitors at 1.2 percent and even lower with the anti-IL-23 monoclon antibodies of 0.24 percent. Bad news regulatory-wise, GSK announced that they halted development of their anti-GMCSF monoclonal antibody called Otilla MAB.